TC BIOPHARM HOLDINGS PLC's ticker is and the CUSIP is 87807D111. A total of 6 filers reported holding TC BIOPHARM HOLDINGS PLC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,176 | -48.8% | 235,294 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $10,118 | -57.0% | 235,294 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $23,506 | +11.7% | 235,294 | 0.0% | 0.00% | +100.0% |
| Q4 2022 | $21,047 | -27.4% | 235,294 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $29,000 | -48.2% | 235,294 | 0.0% | 0.00% | -33.3% |
| Q2 2022 | $56,000 | -52.1% | 235,294 | 0.0% | 0.00% | -40.0% |
| Q1 2022 | $117,000 | – | 235,294 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nantahala Capital Management | 235,294 | $23,506 | 0.00% |
| Altium Capital Management LP | 18,823 | $1,880 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 14,174 | $1,410 | 0.00% |
| ARMISTICE CAPITAL, LLC | 37,648 | $3,761 | 0.00% |
| UBS Group AG | 200 | $20 | 0.00% |